Form 4: ClearPoint Neuro COO Mazin Sabra Reports Stock Transactions

ClearPoint Neuro's Chief Operating Officer, Mazin Sabra, reports the acquisition and disposal of common stock and settlement of restricted stock units on March 6, 2025.

Summary

• On March 6, 2025, Mazin Sabra, the Chief Operating Officer of ClearPoint Neuro, Inc. (CLPT), engaged in transactions involving the company's stock.
• Sabra acquired 13,827 shares of common stock through the settlement of restricted stock units.
• Concurrently, Sabra disposed of 7,022 shares to cover tax withholding obligations related to the vesting of the restricted stock.
• Following these transactions, Sabra directly owns 44,780 shares of ClearPoint Neuro common stock.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about ownership changes.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities and beneficial ownership of company stock. It's a standard practice for publicly traded companies and their executives.

Stakeholder Impact

• Shareholders are informed about changes in insider ownership, which can influence investor confidence.
• The company ensures compliance with SEC regulations regarding insider trading disclosures.

Key Dates